Skip to main content
Dung Le, MD, Oncology, Baltimore, MD

DungThiLeMD

Oncology Baltimore, MD

Hematologic Oncology

Professor of Oncology, Johns Hopkins University School of Medicine

Dr. Le is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Le's full profile

Already have an account?

  • Office

    201 North Broadway Street
    Viragh BLDG 5th FL
    Baltimore, MD 21287
    Phone+1 410-955-8964
    Fax+1 410-367-2194

Summary

  • Dung Le, MD, is an oncologist based in Baltimore, MD, with a subspecialty in Hematologic Oncology. She completed her education and training at the prestigious Johns Hopkins University School of Medicine, where she also completed a fellowship in Hematology and Medical Oncology. Dr. Le has extensive experience in gastrointestinal oncology and general medical oncology, with several publications in reputable journals including the Journal for Immunotherapy of Cancer and Clinical Cancer Research. She is currently involved in multiple clinical trials focusing on advanced solid tumors and pancreatic cancer. In 2013-2014, Dr. Le received the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR, Epic Systems Corporation.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2004 - 2007
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2001 - 2004
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2001

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2004 - 2026
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • PA State Medical License
    PA State Medical License 2024 - 2024
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • ME State Medical License
    ME State Medical License 2020 - 2021
  • OK State Medical License
    OK State Medical License 2021 - 2021
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • KEYNOTE-164: Pembrolizumab for patients with advanced microsatellite instability high (MSI-H) colorectal cancer. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

  • Immunotherapy for Colon Cancer
    Immunotherapy for Colon CancerSeptember 4th, 2019
  • Tumor Gene Testing Urged to Tell if Drug Targets Your Cancer
    Tumor Gene Testing Urged to Tell if Drug Targets Your CancerJuly 6th, 2017
  • Nivolumab Improves OS in Phase III Gastric Cancer Study
    Nivolumab Improves OS in Phase III Gastric Cancer StudyNovember 10th, 2016

Other Languages

  • Vietnamese